InnovAge finishes fiscal 2026 strong, but rate challenges may lie ahead
InnovAge reported Q4 2026 revenue of $262M (up 18.3% YoY) and net income of $9.78M, reversing a $5M loss from Q4 2025. Full-year revenue rose 15.9% to $989M, with a net loss of $683K, improved from $35.3M in 2025. CEO Patrick Blair highlighted operational improvements and growth investments, while CFO Benjamin Adams noted potential rate challenges in 2027.
How this was made
The 30-second read
Why it matters
Earnings beat and narrowed losses suggest operational improvements, but rate pressure remains a key risk.
Market read
Strong Q4 results may prompt short‑term buying, while guidance on a tougher 2027 rate environment adds caution.
What to watch
Potential impact of new leadership and M&A exploration may drive longer‑term growth.
Background
InnovAge is the only publicly traded PACE provider, serving dual‑eligible seniors across six states.
Ticker impact
InnovAge reported Q4 revenue of $262M and a net income of $9.78M, plus full-year revenue of $989M and a narrowed net loss, indicating strong earnings performance.
Potential modest price rise on earnings beat, pending market reaction to rate outlook.
Revenue growth and a swing to profit in Q4 are material; however, guidance on a tougher rate environment tempers upside.
Market effects
Highlights pressure on PACE providers from Medicare/Medicaid rate uncertainty.
California and Colorado rate negotiations could affect other senior‑care operators in those states.
Limited to U.S. value‑care segment.
Counterpoint
If rate cuts materialize, the stock could underperform despite earnings beat.
Key entities
- ExecutivePatrick Blair
CEO of InnovAge, discussed earnings and rate outlook.
- ExecutiveJennifer Browne
New President and COO, former Optum executive.